Min Xu
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 7
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 21
- RNA modifications and cancer 17
- Cancer-related gene regulation 9
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 7
- Immunology top 10%
- Immune cells in cancer 8
-
- Ferroptosis and cancer prognosis 9
- Journals
- Nucleic Acids Research (2 papers)SHILAP Revista de lepidopterología (1 paper)Blood (3 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Min Xu
93 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 1.2k
- Molecular Biology 1.8k
- Oncology 511
- Immunology 256
- Pulmonary and Respiratory Medicine 268
Countries citing papers authored by Min Xu
This map shows the geographic impact of Min Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xu more than expected).
Fields of papers citing papers by Min Xu
This network shows the impact of papers produced by Min Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xu. The network helps show where Min Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 22 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 29 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 15 | |
| 15 | 2021 | 14 | |
| 16 | 2020 | 88 | |
| 17 | 2019 | 64 | |
| 18 | 2012 | 17 | |
| 19 | 2011 | 7 | |
| 20 | 2006 | 42 |
About Min Xu
Min Xu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 101 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), Epigenetics and DNA Methylation (21 papers), RNA modifications and cancer (17 papers), Ferroptosis and cancer prognosis (9 papers), Cancer-related gene regulation (9 papers), Immune cells in cancer (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.8k citations) and Oncology (511 citations). Min Xu has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Aihua Gong, Yin‐Yuan Mo, Youli Zhang, Tsui-Ting Ho, Jianguo Huang, Nanjiang Zhou, F. Du, Wan‐Xin Peng, Junbo He and Fangting Wu. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.